This review provides a background on the genetic aetiologies for obesity and focuses on setmelanotide, its mechanism of action, and its efficacy as a treatment for obesity secondary to a number of genetic variants in the POMC/MC4R pathway. Here, POMC is linked to obesity due to melanocortin 4 receptor deficiency.